“…The quantification of vitamin D found in biological samples presents recognized difficulties (5). This circumstance coincides with an increase in studies to evaluate the content of vitamin D (6,7) occurring over the last decade, which has been attributed to two factors: on the one hand, the prevalence of serious deficiencies of this vitamin in poor countries and, on the other, an increase in the use of vitamin D as a general marker of health status and because of its relationship with various pathologies (8) Therefore, the need for quality research is paramount due to the aforementioned aspects, which cannot be avoided (23). The problem with immunoassays in the preparation of samples is that an antibody that is so specific to such a small antigen must be determined very clearly, in addition to the hydrophobicity of the vitamin and its binding protein (DBP), which would make oscillations in the amount of DBP present in the sample affect the immunoassay.…”